⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride in Extending the Time to Progression of Low-Risk, Localized Prostate Cancer in Men Who Are Candidates for or Undergoing Expectant Management

Study ID: NCT00363311

Study Description

Brief Summary: The purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active therapy (expectant management).

Detailed Description:

Eligibility

Minimum Age: 50 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

GSK Investigational Site, Little Rock, Arkansas, United States

GSK Investigational Site, Beverly Hills, California, United States

GSK Investigational Site, Laguna Hills, California, United States

GSK Investigational Site, Mission Hills, California, United States

GSK Investigational Site, Modesto, California, United States

GSK Investigational Site, San Bernardino, California, United States

GSK Investigational Site, Torrance, California, United States

GSK Investigational Site, Englewood, Colorado, United States

GSK Investigational Site, Wheat Ridge, Colorado, United States

GSK Investigational Site, New Britain, Connecticut, United States

GSK Investigational Site, Trumbull, Connecticut, United States

GSK Investigational Site, Washington, District of Columbia, United States

GSK Investigational Site, Jacksonville, Florida, United States

GSK Investigational Site, Largo, Florida, United States

GSK Investigational Site, Orlando, Florida, United States

GSK Investigational Site, Roswell, Georgia, United States

GSK Investigational Site, Coeur D'Alene, Idaho, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, Melrose Park, Illinois, United States

GSK Investigational Site, Fort Wayne, Indiana, United States

GSK Investigational Site, Newburgh, Indiana, United States

GSK Investigational Site, Overland Park, Kansas, United States

GSK Investigational Site, Shreveport, Louisiana, United States

GSK Investigational Site, Annapolis, Maryland, United States

GSK Investigational Site, Greenbelt, Maryland, United States

GSK Investigational Site, Watertown, Massachusetts, United States

GSK Investigational Site, Minneapolis, Minnesota, United States

GSK Investigational Site, St. Cloud, Minnesota, United States

GSK Investigational Site, Jackson, Mississippi, United States

GSK Investigational Site, St. Louis, Missouri, United States

GSK Investigational Site, Las Vegas, Nevada, United States

GSK Investigational Site, Marlton, New Jersey, United States

GSK Investigational Site, Albuquerque, New Mexico, United States

GSK Investigational Site, Albany, New York, United States

GSK Investigational Site, Elmont, New York, United States

GSK Investigational Site, Garden City, New York, United States

GSK Investigational Site, New York, New York, United States

GSK Investigational Site, Orchard Park, New York, United States

GSK Investigational Site, Syracuse, New York, United States

GSK Investigational Site, Greensboro, North Carolina, United States

GSK Investigational Site, Salisbury, North Carolina, United States

GSK Investigational Site, Winston-Salem, North Carolina, United States

GSK Investigational Site, Columbus, Ohio, United States

GSK Investigational Site, Springfield, Oregon, United States

GSK Investigational Site, Bala Cynwyd, Pennsylvania, United States

GSK Investigational Site, Lancaster, Pennsylvania, United States

GSK Investigational Site, Philadelphia, Pennsylvania, United States

GSK Investigational Site, Memphis, Tennessee, United States

GSK Investigational Site, Nashville, Tennessee, United States

GSK Investigational Site, San Antonio, Texas, United States

GSK Investigational Site, Temple, Texas, United States

GSK Investigational Site, Salt Lake City, Utah, United States

GSK Investigational Site, Richmond, Virginia, United States

GSK Investigational Site, Virginia Beach, Virginia, United States

GSK Investigational Site, Williamsburg, Virginia, United States

GSK Investigational Site, Seattle, Washington, United States

GSK Investigational Site, Seattle, Washington, United States

GSK Investigational Site, Spokane, Washington, United States

GSK Investigational Site, Surrey, British Columbia, Canada

GSK Investigational Site, Victoria, British Columbia, Canada

GSK Investigational Site, Victoria, British Columbia, Canada

GSK Investigational Site, Fredericton, New Brunswick, Canada

GSK Investigational Site, Barrie, Ontario, Canada

GSK Investigational Site, Brampton, Ontario, Canada

GSK Investigational Site, Brantford, Ontario, Canada

GSK Investigational Site, Burlington, Ontario, Canada

GSK Investigational Site, Burlington, Ontario, Canada

GSK Investigational Site, Guelph, Ontario, Canada

GSK Investigational Site, Kitchener, Ontario, Canada

GSK Investigational Site, North Bay, Ontario, Canada

GSK Investigational Site, Oakville, Ontario, Canada

GSK Investigational Site, Scarborough, Ontario, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Chicoutimi, Quebec, Canada

GSK Investigational Site, Greenfield Park, Quebec, Canada

GSK Investigational Site, Laval, Quebec, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Pointe-Claire, Quebec, Canada

GSK Investigational Site, Quebec City, Quebec, Canada

GSK Investigational Site, Trois Rivieres, Quebec, Canada

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: